Skip to search
Skip to main content
Back to Search
Start Over
Treatment of MDS, AML and CMML Relapse after Allogeneic Blood Stem Cell Transplantation with Azacitidine, Lenalidomide and Donor Lymphocyte Infusions Results from the Second Interim Analysis of the Prospective Azalena-Trial (NCT02472691)
Authors :
Schroeder, Thomas Michael Rautenberg, Christina Christopeit, Max Stelljes, Matthias Schmidt, Eva Groth, Christoph Scheid, Christoph Holtick, Udo Klein, Stefan A. Beelen, Dietrich W. Nachtkamp, Kathrin Haas, Rainer Germing, Ulrich Kroeger, Nicolaus Kobbe, Guido Schroeder, Thomas Michael Rautenberg, Christina Christopeit, Max Stelljes, Matthias Schmidt, Eva Groth, Christoph Scheid, Christoph Holtick, Udo Klein, Stefan A. Beelen, Dietrich W. Nachtkamp, Kathrin Haas, Rainer Germing, Ulrich Kroeger, Nicolaus Kobbe, Guido
Publication Year :
2018
Details
Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1201317526
Document Type :
Electronic Resource